Sky Century Investment (SKYI) Cash from Operations (QoQ) (2012 - 2026)
Sky Century Investment (SKYI) Cash from Operations (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -2,813.61% |
| Feb 28, 2026 | 135.15% |
| Nov 30, 2025 | -194.59% |
| Aug 31, 2025 | -89.08% |
| May 31, 2025 | 741.14% |
| Feb 28, 2025 | 13.39% |
| Nov 30, 2024 | -167.71% |
| Aug 31, 2024 | 371.34% |
| May 31, 2024 | 44.40% |
| May 31, 2014 | 77.62% |
| Feb 28, 2014 | 4.07% |
| Nov 30, 2013 | 43.85% |
| Feb 28, 2013 | -940.00% |
| Nov 30, 2012 | 94.53% |